Biovica International AB (publ) (STO:BIOVIC.B)
0.3000
0.00 (0.00%)
Nov 20, 2026, 5:25 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 87.57 million as of November 20, 2026. It is the 41,933rd most valuable company in the world and the 620th biggest in Sweden. Its market cap has decreased by 39.98% in one year.
Market Cap
87.57M
Enterprise Value
42.01M
Revenue
14.93M
Global Rank
Country Rank
#620 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 87.57M, a decrease of -58.30%. That is a compound annual growth rate of -8.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 87.57M | -18.92% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 141.81M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 120.15M |
| IRLAB Therapeutics AB | 111.53M |
| Alzinova AB | 102.88M |
| Active Biotech AB | 92.26M |
| OncoZenge AB | 82.80M |
| Ascelia Pharma AB | 77.98M |